89bio Inc. (ETNB) Announces Two Supervisory Board Additions

Go back to 89bio Inc. (ETNB) Announces Two Supervisory Board Additions

NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth

September 4, 2024 4:15 PM EDT

Dr. Margaret A. Liu, global expert in vaccines, gene therapy, and cancer immunotherapy; chief executive officer of PAX Therapeutics and member of several boardsMs. Anat Naschitz, proven life science investor and entrepreneur; co-founder of OrbiMed Israel

PARIS and CAMBRIDGE, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO NASDAQ: NBTX the Company), a late-clinical stage biotechnology company pioneering nanoparticle-based therapeutic approaches to expand treatment... More